Publications in collaboration with researchers from University of Oxford (15)

2024

  1. Identification of miRNAs and Their Target Genes Associated with Sunitinib Resistance in Clear Cell Renal Cell Carcinoma Patients

    International Journal of Molecular Sciences, Vol. 25, Núm. 13

  2. Non-coding RNA and gene expression analyses of papillary renal neoplasm with reverse polarity (PRNRP) reveal distinct pathological mechanisms from other renal neoplasms

    Pathology, Vol. 56, Núm. 4, pp. 493-503

2021

  1. Integrated mrna and mirna transcriptomic analyses reveals divergent mechanisms of sunitinib resistance in clear cell renal cell carcinoma (Ccrcc)

    Cancers, Vol. 13, Núm. 17

2020

  1. Serum levels of hsa-miR-16-5p, hsa-miR-29a-3p, hsa-miR-150-5p, hsa-miR-155-5p and hsa-miR-223-3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study

    International Journal of Cancer, Vol. 147, Núm. 5, pp. 1315-1324

  2. The urinary transcriptome as a source of biomarkers for prostate cancer

    Cancers, Vol. 12, Núm. 2

2018

  1. Mutational profiling can identify laryngeal dysplasia at risk of progression to invasive carcinoma

    Scientific Reports, Vol. 8, Núm. 1

  2. Noncoding RNA Expression and Targeted Next-Generation Sequencing Distinguish Tubulocystic Renal Cell Carcinoma (TC-RCC) from Other Renal Neoplasms

    Journal of Molecular Diagnostics, Vol. 20, Núm. 1, pp. 34-45

  3. Spatial intratumoural heterogeneity in the expression of GIT1 is associated with poor prognostic outcome in oestrogen receptor positive breast cancer patients with synchronous lymph node metastases

    F1000Research, Vol. 6

2017

  1. DNMT1 is predictive of survival and associated with Ki-67 expression in R-CHOP-treated diffuse large B-cell lymphomas

    Pathology, Vol. 49, Núm. 7, pp. 731-739

2016

  1. New concepts in cancer biomarkers: Circulating miRNAs in liquid biopsies

    International Journal of Molecular Sciences, Vol. 17, Núm. 5

2015

  1. Low HIP1R mRNA and protein expression are associated with worse survival in diffuse large B-cell lymphoma patients treated with R-CHOP

    Experimental and Molecular Pathology, Vol. 99, Núm. 3, pp. 537-545

  2. MicroRNAs as B-cell lymphoma biomarkers

    BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY, Vol. 5, pp. 25-34

  3. The circulating transcriptome as a source of non-invasive cancer biomarkers: Concepts and controversies of non-coding and coding RNA in body fluids

    Journal of Cellular and Molecular Medicine, Vol. 19, Núm. 10, pp. 2307-2323

2014

  1. Targeted next-generation sequencing and non-coding RNA expression analysis of clear cell papillary renal cell carcinoma suggests distinct pathological mechanisms from other renal tumour subtypes

    Journal of Pathology, Vol. 232, Núm. 1, pp. 32-42

2012

  1. Bortezomib action in multiple myeloma: MicroRNA-mediated synergy (and miR-27a/CDK5 driven sensitivity)?

    Blood Cancer Journal